Drug Profile
Research programme: inflammatory bowel disease therapeutics - Toray
Alternative Names: T-728Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Toray
- Class Small molecules
- Mechanism of Action Alpha4beta7 integrin antagonists; Integrin alpha4beta1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory bowel diseases
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammatory-bowel-disease in Japan (PO)
- 22 Oct 2008 Preclinical trials in Inflammatory bowel disease in Japan (PO)